Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-19

Clinical Trial Update: A Trial of SHR7280 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study of SHR7280 in healthy subjects has completed, with associated conditions including endometriosis, uterine fibroids, and infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR7280

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Endometriosis, Uterine Fibroids | Phase 1 | Status: COMPLETED